![PDF) A Comprehensive Review of the Pharmacokinetics of Approved Therapeutic Monoclonal Antibodies in Japan: Are Japanese Phase I Studies Still Needed? PDF) A Comprehensive Review of the Pharmacokinetics of Approved Therapeutic Monoclonal Antibodies in Japan: Are Japanese Phase I Studies Still Needed?](https://i1.rgstatic.net/publication/258638328_A_Comprehensive_Review_of_the_Pharmacokinetics_of_Approved_Therapeutic_Monoclonal_Antibodies_in_Japan_Are_Japanese_Phase_I_Studies_Still_Needed/links/5b6e300a299bf14c6d98cfcb/largepreview.png)
PDF) A Comprehensive Review of the Pharmacokinetics of Approved Therapeutic Monoclonal Antibodies in Japan: Are Japanese Phase I Studies Still Needed?
![PDF) Pharmacokinetics, safety and tolerability of mipomersen in healthy Japanese volunteers and comparison with Western subjects PDF) Pharmacokinetics, safety and tolerability of mipomersen in healthy Japanese volunteers and comparison with Western subjects](https://i1.rgstatic.net/publication/260252695_Pharmacokinetics_safety_and_tolerability_of_mipomersen_in_healthy_Japanese_volunteers_and_comparison_with_Western_subjects/links/56dec78208aedf2bf0c9c78e/largepreview.png)
PDF) Pharmacokinetics, safety and tolerability of mipomersen in healthy Japanese volunteers and comparison with Western subjects
![Safety and Efficacy of Mirogabalin for Peripheral Neuropathic Pain: Pooled Analysis of Two Pivotal Phase III Studies - Clinical Therapeutics Safety and Efficacy of Mirogabalin for Peripheral Neuropathic Pain: Pooled Analysis of Two Pivotal Phase III Studies - Clinical Therapeutics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/38bcb42c-c08e-4105-924d-f1cdb3b09b78/gr1.jpg)
Safety and Efficacy of Mirogabalin for Peripheral Neuropathic Pain: Pooled Analysis of Two Pivotal Phase III Studies - Clinical Therapeutics
![IJERPH | Free Full-Text | Importance and Reality of TDM for Antibiotics Not Covered by Insurance in Japan IJERPH | Free Full-Text | Importance and Reality of TDM for Antibiotics Not Covered by Insurance in Japan](https://www.mdpi.com/ijerph/ijerph-19-02516/article_deploy/html/images/ijerph-19-02516-g001.png)
IJERPH | Free Full-Text | Importance and Reality of TDM for Antibiotics Not Covered by Insurance in Japan
Yan Xu - Vice President, Global Head of Clinical Pharmacology - Simcere Pharmaceutical Group | LinkedIn
Yan Xu - Vice President, Global Head of Clinical Pharmacology - Simcere Pharmaceutical Group | LinkedIn
![PDF) Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory Analysis PDF) Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory Analysis](https://i1.rgstatic.net/publication/345775179_Evolving_Landscape_of_New_Drug_Approval_in_Japan_and_Lags_from_International_Birth_Dates_Retrospective_Regulatory_Analysis/links/5ff2949092851c13fee76d32/largepreview.png)
PDF) Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory Analysis
![Japan's Drug Regulation During the COVID‐19 Pandemic: Lessons From a Case Study of Favipiravir - Ueda - 2022 - Clinical Pharmacology & Therapeutics - Wiley Online Library Japan's Drug Regulation During the COVID‐19 Pandemic: Lessons From a Case Study of Favipiravir - Ueda - 2022 - Clinical Pharmacology & Therapeutics - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/397eade7-0484-4b42-9b1e-34404cfa4192/cpt.v111.3.cover.jpg)
Japan's Drug Regulation During the COVID‐19 Pandemic: Lessons From a Case Study of Favipiravir - Ueda - 2022 - Clinical Pharmacology & Therapeutics - Wiley Online Library
![Ethnic Difference in the Pharmacodynamics‐efficacy Relationship of Dipeptidyl Peptidase‐4 Inhibitors Between Japanese and non‐Japanese Patients: A Systematic Review - Ito - 2017 - Clinical Pharmacology & Therapeutics - Wiley Online Library Ethnic Difference in the Pharmacodynamics‐efficacy Relationship of Dipeptidyl Peptidase‐4 Inhibitors Between Japanese and non‐Japanese Patients: A Systematic Review - Ito - 2017 - Clinical Pharmacology & Therapeutics - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/fc2c8abc-23a0-45ff-9f96-81b95ebdd981/cpt.v102.4.cover.jpg)
Ethnic Difference in the Pharmacodynamics‐efficacy Relationship of Dipeptidyl Peptidase‐4 Inhibitors Between Japanese and non‐Japanese Patients: A Systematic Review - Ito - 2017 - Clinical Pharmacology & Therapeutics - Wiley Online Library
![Frontiers | The Decline and Fall of Materia Medica and the Rise of Pharmacology and Therapeutics in Veterinary Medicine | Veterinary Science Frontiers | The Decline and Fall of Materia Medica and the Rise of Pharmacology and Therapeutics in Veterinary Medicine | Veterinary Science](https://www.frontiersin.org/files/Articles/777809/fvets-08-777809-HTML/image_m/fvets-08-777809-g001.jpg)